• Tidak ada hasil yang ditemukan

Korelasi Ekspresi MicroRNA-155 dengan Grade Histopatologi pada Jaringan Kanker Payudara Tipe Duktal

N/A
N/A
Protected

Academic year: 2019

Membagikan "Korelasi Ekspresi MicroRNA-155 dengan Grade Histopatologi pada Jaringan Kanker Payudara Tipe Duktal"

Copied!
12
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

American Cancer Society. 2013. Breast Cancer.

http://www.cancer.org/acs/groups/cid/documents/webcontent/003090-pdf.pdf. 24th Nov 2013.

American Cancer Society. 2013. Tumor Marker.

http://www.cancer.org/acs/groups/cid/documents/webcontent/003189-pdf.pdf. 24th Nov 2013.

Anderson E. Progesterone receptors – animal models and cell signaling in breast

cancer: The role of oestrogen and progesterone receptors in human

mammary development and tumorigenesis. Breast Cancer Res, 4; 197-201.

Armstrong K., Eisen A., and Weber B. 2000. Assessing the Risk of Breast Cancer.

N Engl J Med 342(8); 564-571.

Australian Government. 2013. Breast Cancer Statistics. Cancer Australia.

http://canceraustralia.gov.au/affected-cancer/cancer-types/breast-cancer/breast-cancer statistics. 24th Nov 2013.

Bartel D.P. 2004. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function.

Cell 116; 281–297.

Beger C., Pierce L.N., Kruger M., Marcusson E.G., Robbins J.M., Welcsh P.,

Welch P.J., Welte K., King M.C., Barber J.R., and Wong-Staal F. 2001.

Identification of Id4 as a Regulator of BRCA1 Expression by Using a

(2)

Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.F., Dunning M.J.,

Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., Tavare S.,

Caldas C., and Miska E.A. 2007. MicroRNA Expression Profiling of Human

Breast Cancer Identifies New Markers of Tumor Subtype. Genome Biology

8(10); R214.1-16.

Bruning U., Cerone L., Neufeld Z., Fitzpatrick S.F., Cheong A, Scholz C.C.,

Simpson D.A. , Leonard M.O., Tambuwala M.M., Cummins E.P., and

Taylor1 C.T. 2011. MicroRNA-155 Promotes Resolution of

Hypoxia-Inducible Factor 1-Activity during Prolonged Hypoxia. Mol Cell Biol

31(19); p. 4087–4096.

Calin GA and Croce CM. 2006.MicroRNA Signatures in Human Cancers. Nature

Rev. Cancer 6; 857-866.

Chen L.J., Lim S.H., Yeh Y.T., Lien S.C., and Chiu J.J. 2012. Roles of

microRNAs in Atherosclerosis and Restenosis. Journal of Biomedical

Science 19(79); 1-13.

Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo

X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C.,

Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J.,

Zen K., Zhang J., and Zhang C. 2008. Characterization of microRNAs in

Serum: a Novel Class of Biomarkers for Diagnosis of Cancer and Other

(3)

Clurman B.E. and Hayward W.S. 1989. Multiple Proto-oncogene Activations in

Avian Leukosis Virus-induced Lymphomas: Evidence for Stage-specific

Events. Mol. Cell. Biol 9(6); 2657-2664.

Connor E.B. and Stuenkel C.A. 2001. Hormone Replacement Therapy

(HRT)-Risk and Benefits. Int J of Epidemiology 30; 423-426.

Cortez M.A., Bueso-Ramos C., Ferdin J., Lopez-Berestein G., Sood A.K., and

Calin G.A. 2011. MicroRNAs in Body Fluids—the Mix of Hormones and

Biomarkers. Nat Rev Clin Oncol 8(8); 467–477.

Cronin P.A., Jiang H Wang J.H., and H Paul Redmond H.P. 2010. Hypoxia

increases the metastatic ability of breast cancer cells via upregulation of

CXCR4. BMC Cancer 10(225); 1-8.

Dağlar G., Yuksek Y.N., Gozalan A.U., Tutuncu T., Gungor Y., and Kama N.A.

2010. The Prognostic Value of Histopatological Grade in the Outcome of

Patients with Invasive Breast Cancer. Turk J Med Sci 40(1); 7-15.

Dahlan M.S. 2010. Besar Sampel dan Cara Pengambilan Sampel dalam

Penelitian Kedokteran dan Kesehatan. Edisi 3. Salemba Medika. Jakarta.

de Jong M.M., Nolte I.M., te Meerman G.J., van der Graaf W.T.A., Oosterwijk

J.C., Kleibeuker J.H., Schaapveld M., and de Vries E.G.E. 2002. Genes

Other than BRCA1 and BRCA2 Involved in Breast Cancer Susceptibility. J

Med Genet 39; 225–242.

DEPKES RI. 2009. Pencegahan Kanker Leher Rahim dan Kanker Payudara.

http://www.pppl.depkes.go.id/_asset/_download/bukusaku_kanker.pdf. 10

(4)

Duffy M.J. and McGing P. 2010. Guidelines for the use of Tumour Markers. 4th

edition. Association of Clinical Biochemists in Ireland.

Ergul E. and Sazci A. 2001. Molecular Genetics of Breast Cancer. Turk J Med Sci

31; 1-14.

Esteller M. 2011.Non-coding RNAs in human disease. Nature 12; 861-874.

Friedman R.C., Farh K.K.H., Burge C.B., Bartel D.P. 2009. Most Mammalian

mRNAs are Conserved Targets of microRNAs. Genome Research 19; 92–

105.

Gasco M., Shami S. and Crook T. 2002. The p53 Pathway in Breast Cancer.

Breast Cancer Res 4; 70-76.

Grazio S.F. and Bracko M. 2002. Long term Prognostic Value of Nottingham

Histopatological Grade and its Components in Early (pT1N0M0) Breast

Carcinoma. J Clin Pathol 55; 88–92.

Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. 2005. Human RISC

Couples microRNA Biogenesis and Posttranscriptional Gene Silencing. Cell

123; 631–640.

Hall J.M., Lee M.K., Newman B., Morrow J.E., Anderson L.A., Huey B., and

King M.C. 1990. Linkage of Early-onset Familial Breast Cancer to

Chromosome 17q21. Science 250; 1684-1689.

Han J., Lee Y., Yeom K.H. 2006. Molecular Basis for the Recognition of Primary

microRNAs by the Drosha-DGCR8 Complex. Cell 125; 887–901.

Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield

(5)

Oncology 2007 Update of Recommendations for the Use of Tumor Markers

in Breast Cancer. J Clin Oncol 25; 5287-5312.

Hauptman N. and Glavac D. 2013. MicroRNAs and Long Non-coding RNAs:

Prospects in Diagnostics and Therapy of Cancer. Radiol Oncol 47(4);

311-318.

Hedenfalk I.A., Ringner M., Trent J.M., and Borg A. 2002. Gene Expression in

Inherited Breast Cancer. Advances in Cancer Research 84; 1-34.

He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S.,

Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., and Hammond S.M.

2005. A microRNA Polycistron as a Potential Human Oncogen. Nature 435;

828-833.

He L., Long L.R., Antani S., Thoma G.R. Computer assisted diagnosis in

histopathology. Chapter 15. National Institutes of Health, USA.

http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1

&cad=rja&uact=8&ved=0CCUQFjAA&url=http%3A%2F%2Ficonceptpre

ss.com%2Fdownload%2Fpaper%2F100531205733.pdf&ei=klhNU7LvEsa_

rgeZ6oGYAg&usg=AFQjCNFfUPakWNN4FzjVNT6NRxpKCgBW6g&bvm=

bv.64764171,d.bmk. 18th Feb 2014.

Henry N.L. and Hayes D.F. 2006. Uses and Abuses of Tumor Markers in the

Diagnosis, Monitoring, and Treatment of Primary and Metastatic Breast

Cancer. The Oncologist 11; 541-552.

Hui A., How C., Ito E., and Liu F. 2011. Micro-RNAs as Diagnostic or Prognostic

(6)

Huntzinger E., Izaurralde E. 2011. Gene Silencing by microRNAs: Contributions

of Translational Repression and mRNA Decay. Nature 12; 99-110.

Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E.,

Pedriali M., Fabbri M., Campiglio M., Me´nard S., Palazzo J.P., Rosenberg

A, Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., and

Croce C.M. 2005. MicroRNA Gene Expression Deregulation in Human

Breast Cancer. Cancer Res 65 (16); 7065-7070.

Kon W., 2010. The Role of MicroRNA-155 in Human Breast Cancer.

Dissertation. the degree of Doctor of Philosophy Department of Pathology

and Cell Biology College of Medicine University of South Florida.

Kumar V., Cotran R.S., dan Robbins SL. 2007. Buku Ajar Patologi Robbins.

Sistem genitalia perempuan dan payudara: Payudara. Edisi 7. EGC.

Jakarta.

Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., and Tuschl T.

2002. Identification of Tissue-Specific MicroRNAs from Mouse. Current

Biology 12; 735–739.

Lee I., Cook N.R., Rexrode K.M., and Buring J.E. 2001. Lifetime physical

activity and risk of breast cancer. British Journal of Cancer 85(7); 962–965.

Lee R.C., Feinbaum R.L., Ambros V. 1993. The C. elegans Heterochronic Gene

lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell

(7)

Lee Y.H., Bedford M.T., and Stallcup M.R. 2011. Regulated recruitment of tumor

suppressor BRCA1 to the p21 gene by coactivator methylation. Genes Dev

25; 176-188.

Loman N., Bladström A., Johannsson O., Borg A., and Olsson H. 2003. Cancer

incidence in relatives of a population-based set of cases of early-onset breast

cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer

Res 5; R175-R186.

Lu Z., Ye Y., Jiao D., Qiao J., Cui S., and Liu Z. 2012. miR-155 and miR-31 are

differentially expressed in breast cancer patients and are correlated with the

estrogen receptor and progesterone receptor status. Oncology Letters 4;

1027-1032.

Mandal A. 2013. Breast Cancer Epidemiology.

http://www.news-medical.net/health/Breast-Cancer-Epidemiology.aspx. 24th Nov 2013.

Mar-Aguilar F., Mendoza-Ram´ırez J.A., Malag´on-Santiago I., Espino-Silva

P.K., Santuario-Facio S.K., Ruiz-Flores P., Rodr´ıguez-Padilla C., and

Res´endez-P´erez D. 2013. Serum circulating microRNA profiling for

identification of potential breast cancer biomarkers. Disease Markers 34;

163–169.

Martinez-Sanchez A., Murphy C.L. 2013. MicroRNA Target

Identification-Experimental Approaches. Biology 2; 189-205.

Mattiske S., Suetani R.J, Neilsen P.M., Callen D.F. 2012. Cancer Epidemiol

(8)

American Association for Cancer Research. cebp.aacrjournals.org. 4th Sept

2013.

Massagué J. 2008. TGFβ in Cancer. Cell 134; 215-230.

McTiernan A., Rajan K.B., Tworoger S.S., Irwin M., Bernstein L., Baumgartner

R., Gilliland F., Stanczyk F.Z., Yasui Y., and Ballard-Barbash R. 2003.

Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors. J

Clin Oncol 21; 1961-1966.

Mendes N.D., Freitas A.T., Sagot M.F. 2009. Current tools for the identification

of miRNA genes and their target. Nucleic Acids Research 37 (8); 2419–

2433.

Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian

S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R., Rosenthal J.,

Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R.,

Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer

S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow

P.K., Norris F.H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett

J.C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R.,

Kamb A., and Skolnick M.H. 1994. A Strong Candidate for the Breast and

Ovarian Cancer Susceptibility Gene BRCA1. Science 266; 66-71.

Mukherjee D. and Zhao J. 2013. The Role of chemokine receptor CXCR4 in

breast cancer metastasis. Am J Cancer Res 3(1); 46-57.

Oakley K.L. and Going J.J. 1995. Specimen Slice Radiography of Cancer in

(9)

Oemiati R., Rahajeng E., Kristanto A.Y. 2011. Prevalensi Tumor dan beberapa

faktor yang Mempengaruhinya di Indonesia. Bul. Penelit. Kesehat 39(4);

190 – 204.

Ostad S.N. and Parsa M. 2011. Breast Cancer from Molecular Point of View:

Pathogenesis and Biomarkers. Chapter 6. Faculty of Pharmacy, Tehran

University of Medical Sciences. Tehran.

http://cdn.intechopen.com/pdfs-wm/24879.pdf. 10th Apr 2014.

Ozsolak F., Poling L.L., Wang Z., Liu H., Liu X.S., Roeder R.G., Zhang X., Song

J.S., Fisher D.E. 2008. Chromatin structure analyses identify miRNA

promoters. Genes Dev 22; 3172-3183.

Pöschl G. and Seitz H.K. 2004. Alcohol and Cancer. Alcohol & Alcoholism 39(3);

pp.155–165.

Rakha E.A., Reis-Filho J.S., Baehner F., Dabbs D.J., Decker T., Eusebi V., Fox

S.B., Ichihara S., Jacquemier J., Lakhani S.R., Palacios J., Richardson A.L.,

Schnitt S.J., Schmitt F.C., Tan P., Tse G.M., Badve S., and Ellis I.O. 2010.

Breast cancer prognostic classifi cation in the molecular era: the role of

histopatological grade. Breast Cancer Research 12; 207.p1-12.

Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., Rougvie,

A.E., Horvitz, H.R., and Ruvkun, G. 2000. The 21- nucleotide let-7 RNA

regulates developmental timing in Caenorhabditis elegans. Nature 403;

(10)

Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. 2004. Identification of

mammalian microRNA host genes and transcription units. Genome Res 14;

1902–1910.

Saini H.K., Griffiths-Jones S., Enright A.J. 2007. Genomic analysis of human

microRNA transcripts. Proc Natl Acad Sci USA 104; 17719–17724.

Sen C.K., Gordillo G.M., Khanna S., Roy S. 2009. Micromanaging Vascular

Biology: Tiny MicroRNAs Play Big Band. J Vasc Res 46; 527–540.

SHEN G, LI X, JIA Y,PIAZZA G.A., and XI Y. 2013. Hypoxia-regulated

microRNAs in human cancer. Acta Pharmacologica Sinica 34; 336–341.

Sjamsuhidajat R. dan de Jong W. 2004. Buku Ajar Ilmu Bedah. Tindakan bedah

organ dan sistem organ: Payudara. Edisi 2. EGC. Jakarta.

Stefansson O.A. and Esteller M. 2012. BRCA1 as a tumor suppressor linked to

the regulation of epigenetic states: keeping oncomiRs under control. Breast

Cancer Research 14; 304.

Szafranska A.E., Davison T.S., Shingara J., Doleshal M., Riggenbach J.A.,

Morrison C.D., Jewell S., and Labourier E. 2008. Accurate Molecular

Characterization of Formalin-Fixed, Paraffin-Embedded Tissues by

microRNA Expression Profiling. JMD 10(5); 415-423.

Taghian AG, Smith BL, Erban JK. 2010. Breast Cancer: A Multidisciplinary

Approach to Diagnosis and Management. Demos Medical. New York.

Tavassoli F.A and Devilee P. 2003. Pathology and Genetics: Tumours of the

Breast and Female Genital Organs. WHO Classification of Tumours;5.

(11)

Terry P.D. and Rohan T.E. 2002. Cigarette Smoking and the Risk of Breast

Cancer in Women: A Review of the Literature. Cancer Epidemiol

Biomarkers Prev 11;953-971.

Tryggvadottir L., Olafsdottir E.J., Gudlaugsdottir S., Thorlacius S., Jon G.,

Jonasson J.G., Tulinius H., and Eyfjord J.E. 2003. BRCA2 mutation carriers,

reproductive factors and breast cancer Risk. Breast Cancer Res 5;

R121-R128.

Valencia-Sanchez M.A.V., Liu J., Hannon G.J., Parker R. 2006. Control of

translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20;

515-524.

Volinia S., Calin G.A., Liu C., Ambs S., Cimmino A., Petrocca F., Visone R.,

Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G.,

Scarpa A., Vecchione A., Negrini M., Harris C.C., and Croce C.M. 2006. A

microRNA expression signature of human solid tumors defines cancer gene

targets. PNAS 103(7); 2257-2261.

Wang F., Zhiguo Zheng Z., Guo J., and Ding X. 2010. Correlation and

quantitation of microRNA aberrant expression in tissues and sera from

patients with breast tumor. Gynecol Oncol doi: 10.1016 /j.ygyno.

2010.07.021; 1-8.

Weir H.K., Thun M.J., Hankey B.F., Ries L.A.G., Howe H.L., Wingo P.A., Jemal

A., Ward E., Anderson R.N., Edwards B.K. 2003. Annual Report to the

(12)

Surveillance Data for Cancer Prevention and Control. J Natl Cancer Inst

95(17); 1276-1299.

WHO. 2013. Breast cancer: prevention and control.

http://www.who.int/cancer/detection/breastcancer/en/. 24th Nov 2013.

Wrensch M., Chew T., Farren G., Barlow J., Belli F., Clarke C., Erdmann C.A.,

Lee M., Moghadassi M., Peskin-Mentzer R., Quesenberry Jr C.P.,

Souders-Mason V., Spence L., Suzuki M. and Gould M. 2003. Risk factors for breast

cancer in a population with high incidence rates. Breast Cancer Res 5;

R88-R102.

Xia W., Cao G.J., Shao N.S. 2009. Progress in miRNA target prediction and

identification. Sci China Ser C-Life Sci 52(12); 1123-1130.

Zhao S.Y., Wu Q., Gao F., Zhang C.B., and Yang X.W. 2012. Serum

microRNA-155 as a potential biomarker for breast cancer screening. Chin Sci Bull 57;

3466-3468.

Zheng W., Zou H., Tan Y., Cai W. 2011. Identification of MicroRNA Target

Genes in Vivo. Mol Biotechnol 47; 200–204.

Zhu W., Qin W., Atasoy, Sauter E.R. 2009. Circulating microRNAs in breast

Referensi

Dokumen terkait

Aplikasi dari konsep sistem rangka pemikul momen dan dengan Tata Cara Perhitungan Struktur Beton Untuk Bangunan Gedung (SNI 03- 2847-2002), maka penulisan ini dengan judul “

Kinerja karyawan memiliki peran yang penting dan strategis dalam mendukung pencapaian visi dan misi DJP, maka kinerja karyawan harus selalu mendapat perhatian yang seksama dari

Misalnya, bila dalam suatu biram a terdapat nada f (pada spasi pertam a) dan terdapat pula nada f tinggi (pada garis ke lim a).

Jumlah dana yang diserap berada di atas target minimum pemerintah sebesar Rp 4 triliun, dan jumlah incoming bids pada lelang kemarin lebih tinggi dibandingkan dengan

• Setiap ekspresi logika dapat bersifat atomik atau majemuk Setiap ekspresi logika dapat bersifat atomik atau majemuk.. tergantung dari variabel proposional yang

Berdasarkan hasil penelitian yang telah dilaksanakan di atas menunjukkan bahwa dengan menggunakan metode bermain peran dapat meningkatkan kemampuan berkomunikasi lisan pada

Oleh karena itu molekul polar yang tidak berhasil sejajar dengan arah medan akan memiliki energi potensial lebih tinggi dari molekul yang tersejajarkan.. Untuk

Dalam hal ini, meskipun guru sudah berupaya sebaik mungkin agar implementasi pendidikan akhlak ini bisa berjalan baik, alangkah lebih baiknya disini peran orang